Global Life Sciences Update
Switzerland to Become First World Health Organization BioHub
September 28, 2021
Spiez, a quaint small town close to the Bernese Alps in Switzerland, will host the first World Health Organization BioHub facility. The objective of this initiative is the safe receipt, storage, and distribution of pathogens to laboratories worldwide to make the fight against them more efficient.
On May 24, 2021, in his speech at the 74th World Health Assembly in Geneva, Swiss Health Minister Alain Berset called for “close international collaboration to ensure the timely sharing of epidemiological and clinical data as well as biological materials.”
One step in that direction was taken on the same day, when Berset and WHO Director-General Tedros Adhanom Ghebreyesus signed a memorandum of understanding (MoU) between the WHO and Switzerland by which the WHO took Switzerland up on its offer to provide space and knowledge for a global pathogen exchange. According to the MoU, Switzerland will make available its Biocontainment Laboratory in Spiez as WHO’s first BioHub.
Currently, most pathogen sharing is done bilaterally between countries and on an ad hoc basis, which can be slow and can leave some countries without access to the benefits and tools. The BioHub is set up to change this and to allow WHO member states to share biological materials with and via the facility, which will serve as a center for the safe receipt, sequencing, storage, and preparation of pathogens for distribution to other laboratories. The objective is to inform risk assessments and sustain global preparedness against pathogens, like the SARS-CoV-2 virus, which may cause an epidemic or even a pandemic.
The BioHub facility is part of WHO’s broader BioHub system for the use of biological materials, which is not limited to state laboratories but also open to other qualified entities such as manufacturers.
One step in that direction was taken on the same day, when Berset and WHO Director-General Tedros Adhanom Ghebreyesus signed a memorandum of understanding (MoU) between the WHO and Switzerland by which the WHO took Switzerland up on its offer to provide space and knowledge for a global pathogen exchange. According to the MoU, Switzerland will make available its Biocontainment Laboratory in Spiez as WHO’s first BioHub.
Currently, most pathogen sharing is done bilaterally between countries and on an ad hoc basis, which can be slow and can leave some countries without access to the benefits and tools. The BioHub is set up to change this and to allow WHO member states to share biological materials with and via the facility, which will serve as a center for the safe receipt, sequencing, storage, and preparation of pathogens for distribution to other laboratories. The objective is to inform risk assessments and sustain global preparedness against pathogens, like the SARS-CoV-2 virus, which may cause an epidemic or even a pandemic.
The BioHub facility is part of WHO’s broader BioHub system for the use of biological materials, which is not limited to state laboratories but also open to other qualified entities such as manufacturers.
律师广告—Sidley Austin LLP 是一家全球性律师事务所。我们的地址及联系方式可在 www.sidley.com/en/locations/offices 查阅。
Sidley 提供本信息仅作为向客户及其他友好人士提供的服务,且仅供教育目的使用。本信息不应被解释或依赖为法律意见,亦不构成律师与客户关系。读者在未寻求专业顾问意见之前,不应依据本信息采取任何行动。Sidley 和 Sidley Austin 指 Sidley Austin LLP 及其关联合伙实体,详见 www.sidley.com/disclaimer。
© Sidley Austin LLP
Offices
Capabilities
Suggested News & Insights
Growth Meets Guardrails: Getting You Ready for the New Realm of Ad/PromoWednesday, May 13, 2026Sidley Represents Galera Therapeutics in Its Merger With Obsidian Therapeutics and US$350 Million Private Placement FinancingApril 21, 2026Sidley Represents Opus Genetics in US$155 Million Financing With Oberland CapitalApril 21, 2026U.S. FDA Issues First Drug Supply Chain Security Act Warning Letter Targeting a Dispenser, Signaling Expanded Enforcement FocusApril 15, 2026Sidley Represents AIP in Its US$1.272 Billion Acquisition of Avanos MedicalApril 14, 2026Sidley Represents Axsome Therapeutics in its Acquisition of Global Rights to Balipodect from TakedaApril 3, 2026
- Stay Up To DateSubscribe to Sidley Publications
- Follow Sidley on Social MediaSocial Media Directory